Evaluating STI screening and antimicrobial resistance in Neisseria gonorrhoeae among PrEP users in Vietnam
评估越南 PrEP 使用者中性传播感染筛查和淋病奈瑟菌耐药性
基本信息
- 批准号:10389089
- 负责人:
- 金额:$ 22.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-05 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAffectAnatomyAntibiotic susceptibilityAntibioticsAntimicrobial ResistanceAntimicrobial susceptibilityAzithromycinCephalosporinsCharacteristicsChlamydia trachomatisCiprofloxacinDataDevelopmentDiagnosticDiagnostic testsElementsEpidemicFoundationsFrequenciesFutureGeneral PopulationGenesGeneticGenetic MarkersGenitourinary systemGenomicsGuidelinesHIVHIV InfectionsHIV riskHealthIncidenceIndividualInfectionKnowledgeLocal GovernmentManuscriptsMedicalMeta-AnalysisModelingMultiple Anatomic SitesNeisseriaNeisseria gonorrhoeaeOropharyngealPenicillin ResistancePhasePredispositionPregnant WomenPrevalencePublishingRapid screeningReportingResearch PersonnelResistanceRiskRisk FactorsSexually Transmitted DiseasesSiteSyphilisTest ResultTestingTrainingUnited NationsUniversitiesVietnamWorkWorld Health Organizationacceptability and feasibilitycohortdata sharingdrug-resistant gonorrheagenome sequencinggenomic locusglobal healthglobal health emergencyhigh risk meninsightlow and middle-income countriesmen who have sex with menpre-exposure prophylaxisprogramsrectalresistant strainroutine screeningsatisfactionscreeningtooltransgender womentransmission processwhole genomewillingness to pay
项目摘要
PROJECT ABSTRACT
Men who have sex with men (MSM) are at higher risk for HIV and sexually transmitted infections (STIs)
that increase HIV risk, such as Neisseria gonorrhoeae and Chlamydia trachomatis. HIV pre-exposure
prophylaxis (PrEP) users—many of whom are MSM—are also at increased risk for STIs. U.S. guidelines
recommend that PrEP users undergo frequent screening in multiple anatomic sites (pharyngeal, urogenital,
and rectal) for asymptomatic infections. However, lower- and middle-income countries (LMICs) lack such
guidelines, resulting in missed opportunities for STI screening and treatment among LMIC PrEP users.
Antimicrobial resistance (AMR) in N. gonorrhoeae is an urgent global health threat and the prevalence is
highest in LMICs, where access to diagnostics is limited. In particular, the Western Pacific Region, which
includes the LMIC of Vietnam, has seen increasing spread of AMR in N. gonorrhoeae, which has spread
worldwide. Major gaps exist in understanding the drivers of AMR in N. gonorrhoeae in LMICs.
In this study, investigators from UCLA and Hanoi Medical University will investigate the acceptability and
feasibility of C. trachomatis and N. gonorrhoeae screening among MSM and transwomen engaged in an HIV
PrEP program in Hanoi, Vietnam. We hypothesize that screening will be acceptable and feasible. We will also
investigate risk factors for AMR and genomic relationships between commensal Neisseria and N. gonorrhoeae
at genetic loci associated with AMR, hypothesizing that recent antibiotic use is a risk factor for AMR.
AIM 1: (a) To determine the distribution of anorectal, pharyngeal, and urogenital C. trachomatis and N.
gonorrhoeae infections among MSM and transgender women PrEP users (n=1,300) in Hanoi, Vietnam and (b)
To evaluate the acceptability and feasibility, including willingness to pay, of rapid, triple-site testing.
AIM 2: (a) To collect, culture, and perform antibiotic susceptibility testing on N. gonorrhoeae and oropharyngeal
Neisseria species to investigate the prevalence and correlates of AMR and b) To perform whole-genome
sequencing on pairs of N. gonorrhoeae and Neisseria species isolated from within the same individual to
investigate relationships within genes associated with antimicrobial resistance in N. gonorrhoeae.
This two-year project has four phases. Phase 1 will last three months and will involve development of study
materials, planning, and training. Phase 2 will last one year and will evaluate acceptability and feasibility of C.
trachomatis and N. gonorrhoeae screening. Phase 3 will last 9 months and will involve antimicrobial
susceptibility testing and whole genome sequencing. Phase 4 will last 3 months and will involve dissemination
of findings through manuscripts, presentations, and sharing of data with local government and health agencies.
Findings from the study will form the foundation for a future R01-proposal to investigate the impact of routine
screening and treatment of STIs on the development of antimicrobial resistance is N. gonorrhoeae.
项目摘要
与男性发生性关系(MSM)的男性面临更高的艾滋病毒和性传播感染的风险(stis)
增加艾滋病毒的风险,例如淋病奈瑟氏菌和沙眼衣原体。艾滋病毒前暴露
预防用户(PREP)用户(其中许多是MSM)也有ETI的风险增加。美国准则
建议在多个解剖部位(咽,泌尿生殖器,,
无症状感染的直肠)。但是,中低收入国家(LMIC)缺乏这样的
指南,导致LMIC Prep用户之间错过了STI筛查和治疗的机会。
淋病。
在LMIC中,获得诊断的限制是最高的。特别是西太平洋地区
包括越南的LMIC,已经看到AMR在N. gonorrhoeae中的传播增加了,它已经传播了
全世界。在LMIC中,了解AMR的驱动因素中存在主要差距。
在这项研究中,UCLA和河内医科大学的研究人员将调查可接受性和
MSM和跨性别者在艾滋病毒中筛查的沙眼梭状疱疹和淋病链球菌的可行性
越南河内的准备计划。我们假设筛查将是可以接受和可行的。我们也会
研究AMR的危险因素以及共生奈瑟氏菌与淋病链球菌之间的基因组关系
在与AMR相关的遗传环境中,假设最近使用抗生素是AMR的危险因素。
AIM 1:(a)确定肛门直肠,咽和泌尿生殖的沙眼和N.的分布。
河内,越南和(b)的MSM和变性女性预备使用者(n = 1,300)的淋病感染(n = 1,300)
评估可接受性和可行性(包括愿意支付的意愿)快速,三个站点测试。
目的2:(a)在淋病和口咽上收集,培养和进行抗生素敏感性测试
奈瑟菌种类研究AMR和B)进行全基因组的患病率和相关性
对从同一个体内部分离到的淋病和奈瑟氏菌对成对进行测序
研究与淋病链球菌中与抗菌素抗性相关的基因之间的关系。
这个为期两年的项目有四个阶段。第1阶段将持续三个月,并将涉及研究
材料,计划和培训。第2阶段将持续一年,并将评估C的可接受性和可行性。
沙眼和淋病。第三阶段将持续9个月,将涉及抗菌素
敏感性测试和整个基因组测序。第4阶段将持续3个月,并将涉及传播
通过手稿,演示和与地方政府和卫生机构共享数据的发现。
该研究的发现将为未来的R01抢劫奠定基础,以调查日常工作的影响
筛查和治疗性传播感染在抗菌耐药性发展方面是淋病猪笼草。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey David Klausner其他文献
Jeffrey David Klausner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey David Klausner', 18)}}的其他基金
Pilot study of linezolid for early syphilis treatment
利奈唑胺治疗早期梅毒的初步研究
- 批准号:
10575509 - 财政年份:2022
- 资助金额:
$ 22.08万 - 项目类别:
Evaluating STI screening and antimicrobial resistance in Neisseria gonorrhoeae among PrEP users in Vietnam
评估越南 PrEP 使用者中性传播感染筛查和淋病奈瑟菌耐药性
- 批准号:
10343849 - 财政年份:2021
- 资助金额:
$ 22.08万 - 项目类别:
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis
比较头孢克肟与青霉素 G 治疗早期梅毒疗效的临床试验
- 批准号:
10417271 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes
性传播感染筛查预防不良分娩和新生儿结局的临床研究
- 批准号:
10555240 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes
性传播感染筛查预防不良分娩和新生儿结局的临床研究
- 批准号:
10385627 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical trial comparing the effectiveness of cefixime versus penicillin G for treatment of early syphilis
比较头孢克肟与青霉素 G 治疗早期梅毒有效性的临床试验
- 批准号:
10079905 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes
性传播感染筛查预防不良分娩和新生儿结局的临床研究
- 批准号:
10322132 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis
比较头孢克肟与青霉素 G 治疗早期梅毒疗效的临床试验
- 批准号:
10652990 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis
比较头孢克肟与青霉素 G 治疗早期梅毒疗效的临床试验
- 批准号:
10392825 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
Clinical study of STI screening to prevent adverse birth and newborn outcomes
性传播感染筛查预防不良分娩和新生儿结局的临床研究
- 批准号:
10082426 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Effects of PrEP Drugs on Female Genital HIV Infection and Women's Reproductive Health
PrEP药物对女性生殖器HIV感染及妇女生殖健康的影响
- 批准号:
10703238 - 财政年份:2022
- 资助金额:
$ 22.08万 - 项目类别:
Effects of PrEP Drugs on Female Genital HIV Infection and Women's Reproductive Health
PrEP药物对女性生殖器HIV感染及妇女生殖健康的影响
- 批准号:
10548694 - 财政年份:2022
- 资助金额:
$ 22.08万 - 项目类别:
Improving Efficacy of Voice Therapy Concepts via Telepractice and Mobile App Technology
通过远程治疗和移动应用技术提高语音治疗概念的功效
- 批准号:
10342353 - 财政年份:2021
- 资助金额:
$ 22.08万 - 项目类别:
Evaluating STI screening and antimicrobial resistance in Neisseria gonorrhoeae among PrEP users in Vietnam
评估越南 PrEP 使用者中性传播感染筛查和淋病奈瑟菌耐药性
- 批准号:
10343849 - 财政年份:2021
- 资助金额:
$ 22.08万 - 项目类别:
Novel role of inflammasome activation in ART neurotoxicity
炎症小体激活在 ART 神经毒性中的新作用
- 批准号:
10163270 - 财政年份:2020
- 资助金额:
$ 22.08万 - 项目类别: